In this area, treatment gaps affect up to 96% of patients, leaving millions without care. The project is funded by the National Institute of Neurological Disorders and Stroke of the NIH.
He is a translational scientist and antibody engineer who specializes in rapid therapeutic development for emerging infectious diseases.
Since its founding in 2005, VIGH has grown from a small team focused on HIV/AIDS research to an institute with projects in more than 20 countries and more than 150 faculty members and staff.
Many of these endowed directorships at VUMC are funded by generous donors who are passionate about making a meaningful difference in research and patient care.
He helped create research training opportunities for doctoral and postdoctoral trainees at Vanderbilt as well as those from low- and middle-income countries.
The grant extension will expand applications in research, clinical trials, registries and national collaborations.